Skip to main content
Clinical Trials/NL-OMON36605
NL-OMON36605
Completed
Not Applicable

Biomarker analysis in septic intensive care patients - The BASIC-study

Academisch Medisch Centrum0 sites2,067 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
blood poisoning
Sponsor
Academisch Medisch Centrum
Enrollment
2067
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age: 18 years and older
  • Presence of an arterial line;Sepsis group: Patients admitted to the intensive care with sepsis, or patients developing sepsis during their stay on the intensive care.;SIRS patients: Critically ill patients who score positive on at least two SIRS criteria who do not suffer from sepsis and have an expected ICU stay of more than 24 hours.;Healthy volunteers: All healthy individuals without any recent febrile or infectious illness (within 2 weeks). Individuals capable of giving written informed consent.

Exclusion Criteria

  • No informed consent;Patients receiving more than 24 hours of antibiotic treatment for a suspected infection prior to ICU admission.;Sepsis group: Previous participation in this study.;SIRS group: Previous participation in this study.;Healthy volunteers: Previous participation in this study.
  • A major illness in the past 3 months or any significant chronic medical illness that the investigator would deem unfavorable for enrolment, including inflammatory diseases.
  • A recent febrile illness (within 2 weeks).
  • Recent use of anti\-inflammatory medication (within 2 weeks).
  • Subject using tobacco and/or illicit drug products.
  • Current use of hormone therapy or current pregnancy.
  • Limited accessibility of a vein in the left or right arm.

Outcomes

Primary Outcomes

Not specified

Similar Trials